Live Breaking News & Updates on Eyepoint Pharmaceuticals Stock Performance

Stay updated with breaking news from Eyepoint pharmaceuticals stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Monashee Investment Management LLC Takes $4.04 Million Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

Monashee Investment Management LLC bought a new stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 175,000 shares of the company’s stock, valued at approximately $4,044,000. EyePoint Pharmaceuticals accounts for about 0.7% of Monashee […] ....

Robertw Baird , Davidr Guyer , Securities Exchange Commission , Quarter For Eyepoint Pharmaceuticals , Investment Advisers , Deutsche Bank , Eyepoint Pharmaceuticals Company Profile , China Universal Asset Management Co , Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Inc , Mirae Asset Global Investments Co , News Ratings For Eyepoint Pharmaceuticals Daily , Monashee Investment Management , Eyepoint Pharmaceuticals Stock Performance , Toth Financial Advisory Corp , Insider Activity At Eyepoint Pharmaceuticals , Free Report , Point Pharmaceuticals , Investment Management , Asset Global Investments , Financial Advisory Corp , China Universal Asset Management , Director David , Exchange Commission , Cormorant Asset Management , One Financial ,

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:EYPT)

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:EYPT)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , Eyepoint Pharmaceuticals Inc , Insider Transactions At Eyepoint Pharmaceuticals , Institutional Investors Weigh In On Eyepoint Pharmaceuticals , Proshare Advisors , Legacy Capital Group California Inc , News Ratings For Eyepoint Pharmaceuticals Daily , Eyepoint Pharmaceuticals Stock Performance , Swiss National Bank , Essex Investment Management Co , Jpmorgan Chase Co , Eyepoint Pharmaceuticals , Free Report , Chardan Capital , Eyepoint Pharmaceutical , One Financial , Point Pharmaceuticals , Get Free Report , Share Advisors , Capital Group California , National Bank , Essex Investment Management , Investment Management , Cormorant Asset Management , Eyepoint Pharmaceuticals Daily ,

Cormorant Asset Management, Lp Buys 581,765 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Stock

Cormorant Asset Management, Lp Buys 581,765 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hermes Inc , Franklin Resources Inc , Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Company Profile , Hedge Funds Weigh In On Eyepoint Pharmaceuticals , First Turn Management , Jennison Associates , Jpmorgan Chase Co , Eyepoint Pharmaceuticals Inc , News Ratings For Eyepoint Pharmaceuticals Daily , Securities Exchange Commission , Quarter For Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Stock Performance , Get Free Report , Cormorant Asset Management , Exchange Commission , Point Pharmaceuticals , Capital One Financial , Eyepoint Pharmaceuticals Daily ,

1,210 Shares in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Bought by FNY Investment Advisers LLC

FNY Investment Advisers LLC bought a new stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) in the 4th quarter, HoldingsChannel reports. The fund bought 1,210 shares of the company’s stock, valued at approximately $27,000. Several other institutional investors have also recently added to or reduced their stakes in the business. Deutsche Bank […] ....

United States , Darioa Paggiarino , Cubist Systematic Strategies , Fny Investment Advisers , Eyepoint Pharmaceuticals Stock Performance , News Ratings For Eyepoint Pharmaceuticals Daily , Deutsche Bank , Quarter For Eyepoint Pharmaceuticals , Jpmorgan Chase Co , American International Group Inc , Tower Research Capital , Eyepoint Pharmaceuticals Profile , Eyepoint Pharmaceuticals Inc , Royal Bank , Eyepoint Pharmaceuticals , Securities Exchange Commission , Free Report , International Group , Systematic Strategies , Research Capital , Point Pharmaceuticals , Get Free Report , Cormorant Asset Management , Exchange Commission , Capital One Financial , Visit Holdingschannel ,

FNY Investment Advisers LLC Buys Shares of 1,210 EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

FNY Investment Advisers LLC purchased a new stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,210 shares of the company’s stock, valued at approximately $27,000. Other hedge funds have also recently […] ....

Darioa Paggiarino , Fny Investment Advisers , Eyepoint Pharmaceuticals Stock Performance , News Ratings For Eyepoint Pharmaceuticals Daily , Barclays Plc , Scotia Capital Inc , Jpmorgan Chase Co , Panagora Asset Management Inc , Quarter For Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals , Securities Exchange Commission , Td Asset Management Inc , Jump Financial , Eyepoint Pharmaceuticals Inc , Free Report , Management Inc , Asset Management , Scotia Capital , One Financial , Point Pharmaceuticals , Get Free Report , Exchange Commission , Cormorant Asset Management , Eyepoint Pharmaceuticals Daily ,